期刊文献+

低雌激素闭经患者激素替代治疗对其骨密度的影响 被引量:1

下载PDF
导出
摘要 目的探讨低雌激素闭经患者激素替代治疗(HRT)对其骨密度的影响。方法选取2012年4月至2014年5月在我院治疗的原发性低雌激素闭经患者57例,观察患者HRT前后骨代谢以及骨密度情况。结果患者L1~4骨密度和股骨颈骨密度分别与血清雌二醇(E2)水平呈正相关(r=0.844、0.916,P〈0.05);治疗后血清降钙素(CT)和空腹尿Ca/Cr分别为(40.11±12.05)pg/L和(0.09±0.03),与治疗前比较差异均有统计学意义(P〈0.05),HRT治疗可使患者血清CT升高,空腹尿Ca/Cr降低;患者治疗后L1~4骨密度和股骨颈骨密度分别为(0.93±0.10)g/cm2和(0.83±0.09)g/cm2,均较治疗前有所提高,差异均有统计学意义(P〈0.05)。结论激素替代治疗可增加低雌激素闭经患者骨密度,在早期防治骨质疏松有重要意义。
出处 《海南医学》 CAS 2015年第16期2451-2453,共3页 Hainan Medical Journal
  • 相关文献

参考文献10

二级参考文献92

  • 1吴丹,杨少琴,李晓林.绝经后骨质疏松症的激素替代治疗[J].中国组织工程研究与临床康复,2001,10(14). 被引量:2
  • 2李启旺,关炳瑜,范程,李二虎,王玉环.持续小剂量性激素加维生素D对绝经期妇女骨质疏松症防治的研究[J].四川医学,2004,25(10):1081-1082. 被引量:2
  • 3吴艳,张雷.替勃龙与氨基酸钙联用治疗绝经后妇女骨质疏松症的观察[J].中国医院药学杂志,2006,26(7):848-849. 被引量:8
  • 4金群华,吴兴临,陆志东.重组人甲状旁腺素促骨合成研究进展[J].国际骨科学杂志,2007,28(2):66-68. 被引量:5
  • 5Cleemann L, Hjerrild BE, Lauridsen AL, et al. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur J Endocrinol, 2009,161:251-257.
  • 6Bakalov VK, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord, 2008,9:145-151.
  • 7Gravhoh CH, Vestergaard P, Hermann AP, et al. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf),2003, 59: 89-96.
  • 8Holroyd CR, Davies JH, Taylor P, et al. Reduced cortical bone density with normal trabeeular bone density in girls with Turner syndrome. Osteoporos Int, 2010, 45: 128-132.
  • 9Bakalov VK, Axelrod L, Baron J, et al. Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab, 2003,88: 5717-5722.
  • 10Ari M, Bakalov VK, Hill S, et al. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome. J Clin Endoerinol Metab, 2006,91:4302- 4305.

共引文献54

同被引文献10

  • 1Seo GH, Kang E, Cho JH,et al. Turner syndrome presented with tall stature due to overdosage of the SHOX gene [J]. Ann Pediatr Endocrinol Metab ,2015,20 : 110-113.
  • 2Boechat MI, Westra SJ, Lippe B. Normal US appearance of ovaries and uterus in four patients with Turner's syndrome and 45, X karyotype [J]. Pediat Radiol, 1996,26 : 37- 39.
  • 3Pitukcheewanont N, Numbenjapon D, Safani S, et al. Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy [J]. Os- teoporos Int ,2011,22 : 1709-1715.
  • 4Carrascosa A, Gussinye M, Terradas P, et al. Spontaneous, but not induced, puberty permits adequate bone mass acqui- sitionin adolescent Turner syndrome patients [J]. J Bone Miner Res,2000,15:2005-2010.
  • 5Faienza MF, Brunetti G, Ventura A, et al. Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome [J]. Bone,2015,81:228-236.
  • 6Soucek O, Lebl J, Snajderova M, et al. Bone geometry and volumetric bone mineral density in girls with Turner syn- drome of different pubertal stages [J]. Clin Endocrinol (Oxf) ,2011,74:445-452.
  • 7Holroyd CR, Davies JH, Taylor P, et al. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome [J]. Osteoporos Int, 2010, 21: 2093-2099.
  • 8Vierncci F, Del Pistoia M, Erba P,et al. Usefulness of phal- angeal quantitative ultrasound in identifying reduced bone mineral status and increased fracture risk in adolescents with Turner syndrome [J]. Hormones, 2014,13 : 353- 360.
  • 9Nakamura T, Tsuburai T, Tokinaga A, et al. Efficacy of es- trogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome [J]. Endocrine Journal,2015,62:965- 970.
  • 10王亚平,陈蓉,林守清,暴蕾.观察低雌激素闭经患者骨密度情况及性激素治疗对其骨密度的影响[J].生殖医学杂志,2014,23(5):351-355. 被引量:7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部